From Surveys to Signals: How AI Is Changing Voice of the Customer in Life Sciences I’ve been spending some time thinking on how Voice of the Customer (VoC) programs are evolving as artificial intelligence (AI) becomes...read more
Category - Blog
From Experimentation to Execution: How 2025 Reset the Trajectory of Healthcare and What 2026 Will Demand
2025 Was Not About Breakthroughs. It Was About Convergence. If 2024 was about proving the possibility of new healthcare ideas, 2025 marked the year that these innovations, across biotech, genomics, diagnostics, digital...read more
Tempus Scoops Up OneOme’s Pharmacogenetics Assets as Precision Medicine Shakeout Continues
Tempus AI has acquired the pharmacogenetics assets of OneOme, a once-promising precision medicine startup that abruptly shut down earlier this year amid financial troubles. The deal marks the latest in a flurry of...read more
New Therapy Potential of Targeted Protein Degradation
New approaches in drug discovery currently focus on the concept of a „magic bullet“ molecule. One that precisely targets an intended pharmacological role without off-target actions or unwanted side-effects. Traditional...read more
